ArticleAmerican journal of preventive medicine2026
Nicotine Pouch Use Among U.S. Adults in 2023 and 2024.
Article in American journal of preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionRecent expansion of U.S. nicotine pouch marketing may increase nicotine pouch use. This study estimated U.S. adult pouch use during 2023-2024 overall and across sociodemographic, cigarette smoking, nicotine vaping, and non-nicotine substance use subgroups.
methodsData were drawn from the nationally representative Monitoring the Future longitudinal panel 2023 and 2024 surveys (N=15,340; ages 19-65 years; 59.6% response rate conditional on Wave 1; analyzed in 2025-2026). Past 12-month and past 30-day nicotine pouch use prevalence was estimated each year in the overall sample and stratified by sociodemographic and substance use status.
resultsIn the overall sample, prevalence increased from 2023 to 2024 for past 12-month (3.4%-5.9%; prevalence ratio=1.75, 95% CI=1.45, 2.13) and past 30-day (2.3%-4.2%; prevalence ratio=1.81, 95% CI=1.44, 2.27) use. Increases in past 12-month prevalence were observed across ages, sexes, and geographies and among non-Hispanic White adults. Past-12-month and past-30-day prevalences increased during 2023-2024 among adults with no past-12-month smoking, never or former vaping, current smoking, with and without current alcohol or cannabis use, and without current other non-nicotine substance use (PRs range:1.53-3.10). No significant cross-year change was observed among those with current vaping, current other non-nicotine substance use, or recent former smoking. Within-year comparisons showed a higher 2024 past 12-month prevalence among young than among older adults, males than females, non-Hispanic White than Black adults, individuals with recent smoking or vaping than those without, and those with current non-nicotine substance use than those without.
conclusionsU.S. adult nicotine pouch use increased from 2023 to 2024 across sociodemographic and nicotine/tobacco use statuses. Further population-level surveillance and longitudinal research on pouch use patterns are warranted.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.